Get startedLog in
    Picture of Quest Diagnostics logo

    DGX — Quest Diagnostics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: FDA Grants Breakthrough Device Designation For Haystack MRD Circulating Tumor DNA Test From Quest Diagnostics

    Picture of Quest Diagnostics logoQuest Diagnostics
    25/08/2025 13:54
    Aug 25 (Reuters) - Quest Diagnostics Inc DGX.N:

FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR HAYSTACK MRD CIRCULATING TUMOR DNA TEST FROM QUEST DIAGNOSTICS

Source text: ID:nPn4TYdKZa

Further company coverage: DGX.N

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Quest Diagnostics

    See all news